Dublin, Nov. 28, 2024 (GLOBE NEWSWIRE) -- The "Exosome Diagnostics & Therapeutics Market by Product, Application, End User - Global Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering.
The Exosome Diagnostics & Therapeutics Market grew from USD 851.08 million in 2023 to USD 1.02 billion in 2024. It is expected to continue growing at a CAGR of 21.27%, reaching USD 3.28 billion by 2030. 
Market growth is driven by increasing prevalence of chronic diseases, advancements in personalized medicine, and technological innovations in exosome isolation and analysis. Additionally, strategic collaborations and investments are enhancing research, further propelling market expansion. Recent acquisitions and partnerships among biopharmaceutical companies have opened potential opportunities, particularly in oncology therapeutics and regenerative medicine.
However, the market faces limitations due to high costs of technology and infrastructure, regulatory hurdles, and inadequate understanding of exosome biology. These challenges suggest a need for standardized protocols, cost-effective manufacturing processes, and enhanced educational initiatives among healthcare providers.
To optimize business growth, companies should focus on enhancing exosome isolation techniques, developing scalable production methods, and exploring novel therapeutic applications such as gene editing and precision oncology. Further research into the molecular composition of exosomes and their functions could unveil new pathways for innovation.
The market nature appears dynamic and competitive, with a strong emphasis on research and collaboration. Companies that successfully address current limitations by investing in cutting-edge research and strategic partnerships will likely gain competitive advantage, thus fostering growth in the exosome diagnostics and therapeutics landscape.
Key Company Profiles
The report delves into recent significant developments in the Exosome Diagnostics & Therapeutics Market, highlighting leading vendors and their innovative profiles. These include AEGLE Therapeutics, AMS Biotechnology, Bio-Techne Corporation, Capital Biosciences, Inc., Capricor Therapeutics, Inc., CUREXSYS GMBH IL, Direct Biologics LLC, Everzom, Evox Therapeutics Limited, EXOGENUS THERAPEUTICS, S.A., ILIAS Biologics Inc., KIMERA LABS, Lonza Group AG, Mercy Bioanalytics, NanoFCM Co., Ltd, NanoSomiX, Inc., NeuroSense Therapeutics Ltd., Promega Corporation, RION, Sienna Cancer Diagnostics Ltd, and System Biosciences, LLC.
The report provides a detailed overview of the market, exploring several key areas:
- Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
- Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
- Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
- Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
- Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.
Additionally, the report addresses key questions to assist stakeholders in making informed decisions:
- What is the current size of the market, and how is it expected to grow?
- Which products, segments, and regions present the most attractive investment opportunities?
- What are the prevailing technology trends and regulatory factors influencing the market?
- How do top vendors rank regarding market share and competitive positioning?
- What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?
Key Attributes
| Report Attribute | Details |
| No. of Pages | 186 |
| Forecast Period | 2024-2030 |
| Estimated Market Value (USD) in 2024 | $1.02 Billion |
| Forecasted Market Value (USD) by 2030 | $3.28 Billion |
| Compound Annual Growth Rate | 21.2% |
| Regions Covered | Global |
Key Topics Covered
1. Preface
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of cases of cancer and other chronic illnesses
5.1.1.2. Increasing government initiatives and campaigns for awareness
5.1.1.3. Expanding applications of exosome-based diagnostics and therapeutics in neurological disorders treatment
5.1.2. Restraints
5.1.2.1. High costs and complex procedures for implementing exosome-based diagnostics
5.1.3. Opportunities
5.1.3.1. Growing trend of personalized medicine tailored to individual patients
5.1.3.2. Technological development of non-invasive diagnostic tools
5.1.4. Challenges
5.1.4.1. Issues associated with standardized protocols for exosome isolation, characterization, and analysis
5.2. Market Segmentation Analysis
5.2.1. Product: Rising use of software in exosome diagnostics and therapeutics owing to database management systems
5.2.2. Application: Emerging applications of exosome diagnostics and therapeutics due to tissue repair and regeneration
5.3. Porter's Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Exosome Diagnostics & Therapeutics Market, by Product
6.1. Introduction
6.2. Instrument
6.3. Reagent
6.4. Software
7. Exosome Diagnostics & Therapeutics Market, by Application
7.1. Introduction
7.2. Diagnostic
7.3. Therapeutic
8. Exosome Diagnostics & Therapeutics Market, by End User
8.1. Introduction
8.2. Cancer Institute
8.3. Diagnostic Center
8.4. Hospital
9. Americas Exosome Diagnostics & Therapeutics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Exosome Diagnostics & Therapeutics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Exosome Diagnostics & Therapeutics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Promega Corporation and INOVIQ Ltd. Forged an Alliance to Revolutionize Cancer Research with Advanced Exosome Biomarker Solutions
12.3.2. Lonza Group AG and NeuroSense Therapeutics Forged Alliance to Enhance Neurodegenerative Disease Research Using Extracellular Vesicle Expertise
12.3.3. Fujifilm Holdings Corporation Unveiled MassivEV Technology for High-Purity, Scalable, and Efficient Applications in Therapeutics and Diagnostics
12.4. Strategy Analysis & Recommendation
For more information about this report visit https://www.researchandmarkets.com/r/m7lb6
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
